Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Adrenocortical Carcinoma

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



computational biology1 - hemorrhagic inflammation1 - primary carcinoid1 - hydronephrosis2 - computed tomography6 - cardiovascular causes1 - radical treatment1 - membranoproliferative glomerulonephritis2 - science translational medicine1 - effective treatment of prostate cancer1 - chronic hereditary nephritis1 - cyclind11 - trabecular bone1 - fetal bladder1 - testosterone therapy1 - kidney stone surgery1 - hypercalciuria5 - kit kat1 - etoposide-doxorubicin-cisplatin1 - autism1 - american society for radiation oncology4 - hypercalcemia1 - hyperpnea1 - fibroids1 - gonadal vessels1 - metastasize1 - kidney disease49 - recurrent infection2 - kidney dysfunction1 - libin cardiovascular institute of alberta1 -